New breast cancer indication for AvastinHoffmann-La Roche's Avastin (bevacizumab for injection) is now indicated for use in combination with paclitaxel for the treatment of patients with metastatic HER2-negative breast cancer who are ECOG (Eastern Cooperative Oncology Group) Class 0-1. Faith leaders urge organ donationsReligious groups unite to promote cause R&D deal on sterilization system Medizone works with Cdn foundation Feds on right track with Halifax lab Will help guide rational drug design New clinic at BC Children's Hospital Provides highly specialized transplant care FPs quietly making changes to improve care CFPC backs grassroots primary-care reform, but slow adoption of health info technology seen as roadblock Yellowknife to host 2012 CMA general council Quebec drug insurance a good model for Canada Dual public-private scheme compulsory for all in province LAST LAUGH: Making health care a business With the right strategy, hospitals can take steps to ensure its customer base grows Pets provide motivation to quit smoking First Previous 2291 2292 2293 2294 2295 Next Last